|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 9/64 |
| (11) | Patento numeris | 2553095 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11713216.7 |
| Europos patento paraiškos padavimo data | 2011-03-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-02-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-10-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/054906 |
| Data | 2011-03-30 |
| (87) | Numeris | WO 2011/121020 |
| Data | 2011-10-06 |
| (30) | Numeris | Data | Šalis |
| 282895 P | 2010-04-16 | US | |
| 10158511 | 2010-03-30 | EP |
| (72) |
GILLJAM, Gustav, SE
WINGE, Stefan, SE
|
| (73) |
Octapharma AG,
Seidenstrasse 2, 8853 Lachen,
CH
|
| (54) | A process for purifying vitamin K dependent proteins such as coagulation factor IX |
| A process for purifying vitamin K dependent proteins such as coagulation factor IX |